MHD II Laboratory Session Cytology APRIL 24, 2014.

53
MHD II Laboratory Session Cytology APRIL 24, 2014

Transcript of MHD II Laboratory Session Cytology APRIL 24, 2014.

Page 1: MHD II Laboratory Session Cytology APRIL 24, 2014.

MHD II Laboratory SessionCytology

APRIL 24, 2014

Page 2: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 1

Page 3: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 1

Q1 Define “cytopathology”

Page 4: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q2 Define the following terms as they relate to cytopathology and give examples:-“exfoliated cells”-”washings”-”brushings”-”fine needle aspirations”

Page 5: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q3 What test is currently the most common clinical application of cytopathology?

Page 6: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 2

Page 7: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 2

CHIEF COMPLAINT:Annual routine physical examination.HISTORY:The patient is a 31 year-old sexually active female, witha history of several partners. She feels healthy, and has nocomplaints.PHYSICAL EXAMINATION:Heart, lung, abdominal exams are normalBreast exam is normal and without massesPelvic exam is unremarkable.A Pap Test is obtained.

Page 8: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q1 For the following patient groups how often is a cervical PAP smear indicated? (use the U.S.P.S.T.F. Guidelines – a link is available on LUMEN under “Vertical Curricula”: “Health Maintenance Screening and Prevention” under “Screening Recommendations”•less than 21 years old

•21-29 years old

•30-65 years old

•>65 years old

•s/p hysterectomy with removal of the cervix and in patients who do not have a history of cervical intraepithelial neoplasia [CIN] grade 2 or 3 or cervical cancer

Page 9: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q2 Is there a role for testing for Human papillomavirus infection in this patient?

Page 10: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q3 Describe the steps required to perform a Pap Test (use the images to help your discussion)

Page 11: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q4 Define “Liquid Based” cytology prep

Q5 Define “Conventional” cytology prep

Page 12: MHD II Laboratory Session Cytology APRIL 24, 2014.

Possible Pap testfindings/interpretations

in patients are

– Normal findings– Evidence of inflammation– Sexually transmitted

diseases– Squamous intraepithelial

lesion– Carcinoma

Page 13: MHD II Laboratory Session Cytology APRIL 24, 2014.

Normal cervix cytology/histologyQ6 Describe the normal histologyCorrelate the cytology findings with the histology

Page 14: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q7 Make a diagnosis based on each of the following PAP smearsYour options are:-Evidence of acute inflammation-Herpes simplex virus infection-Trichomonas infection-Human Papillomavirus infection-Squamous cell carcinoma(hints are provided)

Page 15: MHD II Laboratory Session Cytology APRIL 24, 2014.

A

Page 16: MHD II Laboratory Session Cytology APRIL 24, 2014.

B

Page 17: MHD II Laboratory Session Cytology APRIL 24, 2014.

Cnormal

Page 18: MHD II Laboratory Session Cytology APRIL 24, 2014.

DHigh Power

Correlative tissue section

Page 19: MHD II Laboratory Session Cytology APRIL 24, 2014.

E

hint

Page 20: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q8 An HPV test is performed in this patient and reveals the presence of a high-risk type of the virus. What is the chance that she will develop a cervical cancer?

Page 21: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q9 If a woman receives the HPV vaccine does she still need routine Pap Tests?

Page 22: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 3

Page 23: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 3

CHIEF COMPLAINT:“I see blood in my urine”.

HISTORY:The patient is a 72 year-old-man with a history of low-grade

urothelial carcinoma.

PHYSICAL EXAMINATION:Physical examination is unremarkable

LAB TESTS:Urinalysis – Numerous RBC’s.

Page 24: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q1 What is the main clinical problem?

Q2 Develop a differential diagnosis for this problem.

Page 25: MHD II Laboratory Session Cytology APRIL 24, 2014.

Diagnostic Work-upCystoscopy did not revealany papillarytumors, but did show focalerythematous areas.

Bladder washing(barbotage) was performedand the specimen wassubmitted forcytologic examination.

Page 26: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q3 Describe the findings in urine specimen (compare to normal, are the cells cytologically benign or malignant?)

Normal urothelial cell

Page 27: MHD II Laboratory Session Cytology APRIL 24, 2014.

The urologist performs a followup bladder biopsy to confirm the diagnosis.

Page 28: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q4 Describe the histologic findings.

Normal bladder

Page 29: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q5 Does the histology correlate with the cytology?

Page 30: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q6 What is your diagnosis?

Q7 What molecular changes can youexpect in this patient’s urothelium?

Page 31: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 4

Page 32: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 4CHIEF COMPLAINT:“I found a lump in my neck.”HISTORY:The patient is a 55 year-old-woman with a history of

radiation to the neck 20 years ago for hyperthyroidism.PHYSICAL EXAMINATION:A nodule is palpated in the right lobe of the thyroid gland (2

cm) and also an enlarged right cervical lymph node is present.

LAB TESTS:Thyroid function tests were normal. Ultrasound confirmed

the presence of a 2 cm nodule in the right thyroid and an enlarged lymph node. It was a “cold” nodule on scintiscan.

Page 33: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q1 What is the main clinical problem?

Page 34: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q2 A fine needle aspiration (FNA) biopsy is performed. Compare/contrast what is being done in each of the photos below

Page 35: MHD II Laboratory Session Cytology APRIL 24, 2014.

What are the advantages of FNA? What are the advantages of FNA?

• FNA is SAFE – – Simple, Accurate, Fast

and Economic– as well as safe – the best safety record

of any method of procuring tissue for a morphologic diagnosis

Page 36: MHD II Laboratory Session Cytology APRIL 24, 2014.

Describe characteristic cytologic findings.

Normal thyroid cytologyQ3 What is the cell type present?What structure are the cells forming?

Page 37: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q4 Patient specimen. What “structure” are the cells forming?

Hint – histology correlate

Page 38: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q5 Describe characteristic cytologic features of the cells

Page 39: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q6 What is depicted in the image?

Hint – histologycorrelate

Page 40: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q7 What is your diagnosis?

Q8 What molecular changes are associated with this lesion?

Page 41: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q9 What is the patient’s prognosis?

Page 42: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 5

Page 43: MHD II Laboratory Session Cytology APRIL 24, 2014.

Case 5

CHIEF COMPLAINT:“My stomach hurts”.HISTORY:The patient is a 72 year-old woman who presents with

vague abdominal pain for the past several months. She denies nausea, vomiting and blood in her stool.

PHYSICAL EXAMINATION:The patient is alert and oriented. Vital signs are normal.

Her abdominal exam reveals normal bowel sounds with no tenderness to palpation or rebound tenderness. On rectal exam stool is brown and hemoccult negative.

Page 44: MHD II Laboratory Session Cytology APRIL 24, 2014.

CT scan abdomenCT scan reveals a 4 cm well-demarcated exophytic mass

extending into the gastric lumen.

Mayo Clinical Proceeding; Volume 83(4), April 2008, p 384

Page 45: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q1 Develop a differential diagnosis for a gastric mass.

Page 46: MHD II Laboratory Session Cytology APRIL 24, 2014.

As part of the workup, esophagogastroduodenoscopy was performed, revealing a gastric sub-mucosal mass. This mass was arising from the muscularis propria. Endoscopic ultrasound-guided fine needle aspiration (EUS FNA) was performed.Q2 Briefly describe what an “EUS FNA” is.

Page 47: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q3. Describe cytologic findings (hint focus on the shape of the cells)

Page 48: MHD II Laboratory Session Cytology APRIL 24, 2014.

High power

Page 49: MHD II Laboratory Session Cytology APRIL 24, 2014.

Immunohistochemical stains are performed.

C-kit (CD 117)

Page 50: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q4 What is your diagnosis?

Page 51: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q5 Describe the intro-op findings

Mayo Clinical Proceeding; Volume 83(4), April 2008, p 384

Page 52: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q6 Name the cell of origin for this tumor

Q7 With what syndrome(s) is this tumor associated?

Page 53: MHD II Laboratory Session Cytology APRIL 24, 2014.

Q8 What is Imatinib?